• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: September 16-20, 2013

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

September 16-20, 2013
FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs9/16/13Silver Spring, MDJeanne Ireland, Robert Guidos, Jeff Shuren, Michelle McMurray-Heath, Virginia Cox, Karen Riley, Cara Tenebaum, Robert Temple, Heidi Marchand, Patricia Kuntze, Jeffrey Shiffman, Kristy MoranDiana Zuckerman (National Research Center for Women and Families); Sally Greenberg (National Consumer League); Kim Witzak (Woody Matters); Jean Silver-Isenstadt (National Physicians Alliance); Lisa Tate (WomenHeart); Thomas J. Moore (Institute for Safe Medication Practices); Celia Wexler (Union of Concerned Scientists); Amy Allina (National Women's Health Network); Susan Wood (George Washington University); Rachel Breman (Our Bodies Ourselves); Teddy Fagrelius (American Medical Student Association); Michale Russo (U.S. PIRG)Patient, Consumer, and Public Health Coalition Concerns about Expedited Pathways and Patient-Centered Outcomes for Drugs and Device Classification Issues
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs9/18/13Washington, DCMary Lou ValdezN/ACode of Federal Regulations (CFR) Meeting:  Ensuring the Safety and Quality of the Global Supply Chain For Medicines
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs9/19/13Washington, DCN/AN/ADebriefing Meeting for Public Health Regulators
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs9/19/13Washington, DCN/AN/AMassachusetts Institute of Technology (MIT) NEW Drug Development ParadIGmS (NEWDIGS) Adaptive Licensing Initiative Meeting
John M. Taylor, III, Counselor to the Commissioner and Acting Deputy Commissioner for Global Regulatory Operations and Policy9/19/13Silver Spring, MDKaren Midthun, Mary Malarkey, Peter Lurie, Evelyn Bonnin, Richard Davey, Annamarie Kempic, Michele SvonkinShaun Gilmore and several representatives (American Red Cross)American Red Cross
Virginia Cox, Associate Commissioner for External Affairs9/16/13-9/20/13N/AN/AN/ANo Significant Meetings
Elizabeth H. Dickinson, Esq., Chief Counsel9/16/13-9/20/13N/AN/AN/ANo Significant Meetings
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine9/19/13Rockville, MDWilliam Flynn, Steve VaughnKJ Varma, David Yates, John Hutchinson, John Rogers (Merck Animal Health)Overview of the Drug Approval Process
Jesse Goodman, M.D., M.P.H., Chief Scientist9/16/13Washington, DCN/ASteve Binion, Noel Harvey (Becton, Dickinson and Company)BD Technologies Initiatives, Technology Development and Collaboration Opportunities Related to Public Health and Regulatory Science
Walter S. Harris, M.B.A., P.M.P., Deputy Commissioner for Operations and Chief Operating Officer9/16/13-9/20/13N/AN/AN/ANo Significant Meetings 
Sally Howard, J.D., Deputy Commisioner for Policy, Planning and Legislation and Acting Associate Commissioner for Legislation9/16/13-9/20/13N/AN/AN/ANo Significant Meetings
Michael M. Landa, J.D., Director, Center for Food Safety and Applied Nutrition9/16/13-9/18/13Burr Ridge, ILN/AN/AInstitute for Food Safety and Health (IFSH) Annual Meeting 
Peter Lurie, M.D., M.P.H., Acting Associate Commissioner for Policy and Planning9/16/13-9/20/13N/AN/AN/ANo Significant Meetings
Karen Midthun, M.D., Director, Center for Biologics Evaluation and Research9/16/13-9/20/13N/AN/AN/ANo Significant Meetings
Melinda K. Plaiser, Associate Commissioner for Regulatory Affairs9/16/13-9/20/13N/AN/AN/ANo Significant Meetings
Jeffrey E. Shuren, M.D., J.D., Director, Center for Devices and Radiological Health9/18/13Washington, DCN/AN/AHealthcare Information and Management Systems Society, Government Relations Roundtable, Small Business and Diversity Roundtable, and Legal Task Force Face-to-Face Joint Meeting 
Jeffrey E. Shuren, M.D., J.D., Director, Center for Devices and Radiological Health9/20/13Silver Spring, MDN/AJay Schnitzer, Erin Williams, Heather Hawley (The MITRE Corporation)Meet and Greet
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research9/16/13-9/20/13N/AN/AN/ANo Significant Meetings
Michael R. Taylor, J.D., Deputy Commissioner for Foods and Veterinary Medicine9/18/13Ottawa, OntarioCamille Brewer, Charlotte Christin, Julie Callahan, Samir Assar, Vinetta Howard-King, Sema HashemiPaul Mayers, Martine Dubuc, Colleen Barnes, Lyzette Johnson, Daintry Gordon, Richard Arsenault, Mark Burgham and several representatives (Canadian Food Inspection Agency); Anne Lamar, Samuel Godefroy, Maria Nazarowec-White, Danielle Brule' and several representatives (Health Canada)Canada's Implementation of the Safe Food for Canadians Act and FDA's Food Safety Modernization Act
Michael R. Taylor, J.D., Deputy Commissioner for Foods and Veterinary Medicine9/19/13- 9/20/13Washington, DC Brian Pendleton, Kari Barrett, Roberta Wagner, Domenic Veneziano, Pirouz Foroutan, Edward Puro, Samir Asar, Jenny Scott, Charlotte Christin, Sharon MaylMembers of the general publicFood Safety Modernization Act Public Meeting on Proposed Rules on Foreign Supplier Verification Programs and the Accreditation of Third-Party Auditors
Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs9/16/13-9/20/13N/AN/AN/ANo Significant Meetings
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs9/16/13-9/20/13N/AN/AN/ANo Significant Meetings
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research9/17/13Washington, DCJeff Shuren, Theresa MullinSusan Peschin (Alliance for Aging Research); Danelle Miller (Roche Diagnostics)Alliance for Aging Research A Roundtable Discussion with the FDA One Year Later: The Food and Drug Administration Safety and Innovation Act and Its Impact for Diseases of Aging
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research9/15/13-9/16/13Washington, DCPaula Katz, Pankaj Amin, Laurie NorwoodShane Killian (Johnson and Johnson); Stephan Roenninger (Amgen Europe); Maria Guazzaroni Jacobs (Pfizer)2013 PDA/FDA Joint Regulatory Conference
Mitchell R. Zeller, J.D., Director, Center for Tobacco Products9/19/13Wichita, KSN/AConference Participants Kansas Health Foundation, Tobacco Free Kansas Coalition and Kansas Public Health Association (KPHA) Annual Meeting